{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T07:33:10Z","timestamp":1672990390877},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00292-021-00937-6","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T20:02:55Z","timestamp":1617739375000},"page":"294-304","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Histologische Subtypen des Nierenzellkarzinoms"],"prefix":"10.1007","volume":"42","author":[{"given":"I.","family":"Polifka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Agaimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Moch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"937_CR1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1586\/14737140.1.4.576","volume":"1","author":"B Delahunt","year":"2001","unstructured":"Delahunt\u00a0B, Velickovic\u00a0M, Grebe\u00a0SK (2001) Evolving classification of renal cell neoplasia. Expert Rev Anticancer Ther 1:576\u2013584","journal-title":"Expert Rev Anticancer Ther"},{"key":"937_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G","volume":"183","author":"G Kovacs","year":"1997","unstructured":"Kovacs\u00a0G, Akhtar\u00a0M, Beckwith\u00a0BJ et\u00a0al (1997) The Heidelberg classification of renal cell tumours. J\u00a0Pathol 183:131\u2013133","journal-title":"J Pathol"},{"key":"937_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00184870","volume":"13","author":"S St\u00f6rkel","year":"1995","unstructured":"St\u00f6rkel\u00a0S, Van Den Berg\u00a0E (1995) Morphological classification of renal cancer. World J Urol 13:153\u2013158","journal-title":"World J Urol"},{"key":"937_CR4","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","volume":"37","author":"JR Srigley","year":"2013","unstructured":"Srigley\u00a0JR, Delahunt\u00a0B, Eble\u00a0JN et\u00a0al (2013) The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia. Am J Surg Pathol 37:1469\u20131489","journal-title":"Am J Surg Pathol"},{"key":"937_CR5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00292-016-0144-1","volume":"37","author":"H Moch","year":"2016","unstructured":"Moch\u00a0H (2016) WHO classification 2016 and first S3 guidelines on renal cell cancer: what is important for the practice? Pathologe 37:127\u2013133","journal-title":"Pathologe"},{"key":"937_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch\u00a0H, Cubilla\u00a0AL, Humphrey\u00a0PA et\u00a0al (2016) The 2016 WHO classification of tumours of the urinary system and Male genital organs\u2014Part A: renal, penile, and testicular tumours. Eur Urol 70:93\u2013105","journal-title":"Eur Urol"},{"key":"937_CR7","first-page":"557","volume":"12","author":"C Perne","year":"2020","unstructured":"Perne C, Steinke-Lange V, Aretz S, Spier I (2020) Seltene Tumoren als Leitsymptom heredit\u00e4rer Tumorsyndrome. Best Pract Onkol 12:557\u2013558","journal-title":"Best Pract Onkol"},{"key":"937_CR8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00761-019-0571-8","volume":"25","author":"F Erlmeier","year":"2019","unstructured":"Erlmeier\u00a0F, Agaimy\u00a0A, Hartmann\u00a0A et\u00a0al (2019) Pathologie und Molekularpathologie des Nierenzellkarzinoms. Onkologe 25:497\u2013511","journal-title":"Onkologe"},{"key":"937_CR9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13865","volume":"75","author":"K Trpkov","year":"2019","unstructured":"Trpkov\u00a0K, Williamson\u00a0SR, Gao\u00a0Y et al (2019) Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7\u2011positive): a\u00a0distinct entity? Histopathology 75:174\u2013184","journal-title":"Histopathology"},{"key":"937_CR10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-2559.2010.03726.x","volume":"57","author":"K Trpkov","year":"2010","unstructured":"Trpkov\u00a0K, Yilmaz\u00a0A, Uzer\u00a0D et\u00a0al (2010) Renal oncocytoma revisited: a\u00a0clinicopathological study of 109\u00a0cases with emphasis on problematic diagnostic features. Histopathology 57:893\u2013906","journal-title":"Histopathology"},{"key":"937_CR11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-018-2456-4","volume":"473","author":"H He","year":"2018","unstructured":"He\u00a0H, Trpkov\u00a0K, Martinek\u00a0P et al (2018) \u201cHigh-grade oncocytic renal tumor\u201d: morphologic, immunohistochemical, and molecular genetic study of 14\u00a0cases. Virchows Arch 473:725\u2013738","journal-title":"Virchows Arch"},{"key":"937_CR12","doi-asserted-by":"crossref","first-page":"S350","DOI":"10.21037\/atm.2019.09.77","volume":"7","author":"S Mikami","year":"2019","unstructured":"Mikami\u00a0S, Kuroda\u00a0N, Nagashima\u00a0Y et\u00a0al (2019) Classification of solid renal tumor with oncocytic\/eosinophilic cytoplasm: is hybrid oncocytic\/chromophobe renal tumor a\u00a0subtype of oncocytoma, chromophobe renal cell carcinoma, or a\u00a0distinct tumor entity? Ann Transl Med 7:S350\u2013S350","journal-title":"Ann Transl Med"},{"key":"937_CR13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00428-010-0898-4","volume":"456","author":"F Petersson","year":"2010","unstructured":"Petersson\u00a0F, Gatalica\u00a0Z, Grossmann\u00a0P et\u00a0al (2010) Sporadic hybrid oncocytic\/chromophobe tumor of the kidney: a\u00a0clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14\u00a0cases. Virchows Arch 456:355\u2013365","journal-title":"Virchows Arch"},{"key":"937_CR14","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41379-019-0304-y","volume":"32","author":"R Ruiz-Cordero","year":"2019","unstructured":"Ruiz-Cordero\u00a0R, Rao\u00a0P, Li\u00a0L et al (2019) Hybrid oncocytic\/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma. Mod Pathol 32:1698\u20131707","journal-title":"Mod Pathol"},{"key":"937_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2020.12.006","author":"MY Tjota","year":"2020","unstructured":"Tjota MY, Wanjari P, Segal J et\u00a0al (2020) TSC\/MTOR mutated eosinophilic renal tumors are a\u00a0distinct entity that are CK7+\/CK20\u2212\/vimentin\u2212: a\u00a0validation study. Hum Pathol https:\/\/doi.org\/10.1016\/j.humpath.2020.12.006","journal-title":"Hum Pathol"},{"key":"937_CR16","doi-asserted-by":"crossref","unstructured":"Kwon R, Argani P, Epstein JI et\u00a0al Contemporary characterization and recategorization of adult unclassified renal cell carcinoma. Am J Surg Pathol 45:450\u2013462","DOI":"10.1097\/PAS.0000000000001629"},{"key":"937_CR17","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","volume":"37","author":"B Delahunt","year":"2013","unstructured":"Delahunt\u00a0B, Cheville\u00a0JC, Martignoni\u00a0G et\u00a0al (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 37:1490\u20131504","journal-title":"Am J Surg Pathol"},{"key":"937_CR18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00292-014-2030-z","volume":"36","author":"G Kristiansen","year":"2015","unstructured":"Kristiansen\u00a0G, Delahunt\u00a0B, Srigley\u00a0JR et\u00a0al (2015) Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP). Pathologe 36:310\u2013316","journal-title":"Pathologe"},{"key":"937_CR19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/PAS.0b013e3182496895","volume":"36","author":"JC Cheville","year":"2012","unstructured":"Cheville\u00a0JC, Lohse\u00a0CM, Sukov\u00a0WR et\u00a0al (2012) Chromophobe renal cell carcinoma: the impact of tumor grade on outcome. Am J Surg Pathol 36:851\u2013856","journal-title":"Am J Surg Pathol"},{"key":"937_CR20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1464-410X.2011.10690.x","volume":"110","author":"A Volpe","year":"2012","unstructured":"Volpe\u00a0A, Novara\u00a0G, Antonelli\u00a0A et\u00a0al (2012) Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a\u00a0large multicentre series. BJU Int 110:76\u201383","journal-title":"BJU Int"},{"key":"937_CR21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/modpathol.2010.78","volume":"23","author":"S Halat","year":"2010","unstructured":"Halat\u00a0S, Eble\u00a0JN, Grignon\u00a0DJ et\u00a0al (2010) Multilocular cystic renal cell carcinoma is a\u00a0subtype of clear cell renal cell carcinoma. Mod Pathol 23:931\u2013936","journal-title":"Mod Pathol"},{"key":"937_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1309\/AH6FC77PYR2V6YAY","volume":"125","author":"S Suzigan","year":"2006","unstructured":"Suzigan\u00a0S, L\u00f3pez-Beltr\u00e1n\u00a0A, Montironi\u00a0R et al (2006) Multilocular cystic renal cell carcinoma: a report of 45 cases of a\u00a0kidney tumor of low malignant potential. Am J Clin Pathol 125:217\u2013222","journal-title":"Am J Clin Pathol"},{"key":"937_CR23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/2159-8290.CD-16-0267","volume":"6","author":"R Mehra","year":"2016","unstructured":"Mehra\u00a0R, Vats\u00a0P, Cieslik\u00a0M et\u00a0al (2016) Biallelic alteration and dysregulation of the hippo pathway in mucinous tubular and spindle cell carcinoma of the kidney. Cancer Discov 6:1258\u20131266","journal-title":"Cancer Discov"},{"key":"937_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00120-019-01108-5","volume":"59","author":"NJ Rupp","year":"2020","unstructured":"Rupp\u00a0NJ, Moch\u00a0H (2020) Charakterisierung der unterschiedlichen Entit\u00e4ten beim Nierenzellkarzinom. Urologe 59:135\u2013141","journal-title":"Urologe"},{"key":"937_CR25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato\u00a0Y, Yoshizato\u00a0T, Shiraishi\u00a0Y et al (2013) Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 45:860\u2013867","journal-title":"Nat Genet"},{"key":"937_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38986","author":"J Xu","year":"2019","unstructured":"Xu J, Reznik E, Lee HJ et\u00a0al (2019) Abnormal oxidative metabolism in a\u00a0quiet genomic background underlies clear cell papillary renal cell carcinoma. Elife 8 https:\/\/doi.org\/10.7554\/eLife.38986","journal-title":"Elife"},{"key":"937_CR27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00292-016-0158-8","volume":"37","author":"A Agaimy","year":"2016","unstructured":"Agaimy\u00a0A (2016) Succinate dehydrogenase (SDH)-deficient renal cell carcinoma. Pathologe 37:144\u2013152","journal-title":"Pathologe"},{"key":"937_CR28","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill\u00a0AJ, Hes\u00a0O, Papathomas\u00a0T et al (2014) Succinate dehydrogenase (SDH)-deficient renal carcinoma: a\u00a0morphologically distinct entity: a\u00a0clinicopathologic series of 36 tumors from 27\u00a0patients. Am J Surg Pathol 38:1588\u20131602","journal-title":"Am J Surg Pathol"},{"key":"937_CR29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PAS.0000000000000787","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy\u00a0A, Cheng\u00a0L, Egevad\u00a0L et\u00a0al (2017) Rhabdoid and undifferentiated phenotype in renal cell carcinoma: analysis of 32\u00a0cases indicating a\u00a0distinctive common pathway of dedifferentiation frequently associated with SWI\/SNF complex deficiency. Am J Surg Pathol 41:253\u2013262","journal-title":"Am J Surg Pathol"},{"key":"937_CR30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/j.semdp.2018.01.002","volume":"35","author":"A Agaimy","year":"2018","unstructured":"Agaimy\u00a0A, Foulkes\u00a0WD (2018) Hereditary SWI\/SNF complex deficiency syndromes. Semin Diagn Pathol 35:193\u2013198","journal-title":"Semin Diagn Pathol"},{"key":"937_CR31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/modpathol.2008.44","volume":"21","author":"JX Cheng","year":"2008","unstructured":"Cheng\u00a0JX, Tretiakova\u00a0M, Gong\u00a0C et\u00a0al (2008) Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol 21:647\u2013652","journal-title":"Mod Pathol"},{"key":"937_CR32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1093526617749671","volume":"21","author":"BR Pawel","year":"2018","unstructured":"Pawel\u00a0BR (2018) SMARCB1-deficient tumors of childhood: a practical guide. Pediatr Dev Pathol 21:6\u201328","journal-title":"Pediatr Dev Pathol"},{"key":"937_CR33","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","volume":"31","author":"MJ Merino","year":"2007","unstructured":"Merino\u00a0MJ, Torres-Cabala\u00a0C, Pinto\u00a0P et al (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31:1578\u20131585","journal-title":"Am J Surg Pathol"},{"key":"937_CR34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","volume":"38","author":"YB Chen","year":"2014","unstructured":"Chen\u00a0YB, Brannon\u00a0AR, Toubaji\u00a0A et al (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol 38:627\u2013637","journal-title":"Am J Surg Pathol"},{"key":"937_CR35","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e318227e7f4","volume":"35","author":"AJ Gill","year":"2011","unstructured":"Gill\u00a0AJ, Pachter\u00a0NS, Chou\u00a0A et\u00a0al (2011) Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol 35:1578\u20131585","journal-title":"Am J Surg Pathol"},{"key":"937_CR36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","volume":"10","author":"HJ Lehtonen","year":"2011","unstructured":"Lehtonen\u00a0HJ (2011) Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer 10:397\u2013411","journal-title":"Fam Cancer"},{"key":"937_CR37","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","volume":"31","author":"M Muller","year":"2018","unstructured":"Muller\u00a0M, Guillaud-Bataille\u00a0M, Salleron\u00a0J et al (2018) Pattern multiplicity and fumarate hydratase (FH)\/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration. Mod Pathol 31:974\u2013983","journal-title":"Mod Pathol"},{"key":"937_CR38","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.5858\/arpa.2018-0216-RA","volume":"142","author":"SL Skala","year":"2018","unstructured":"Skala\u00a0SL, Dhanasekaran\u00a0SM, Mehra\u00a0R (2018) Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC): a contemporary review and practical discussion of the differential diagnosis for HLRCC-associated renal cell carcinoma. Arch Pathol Lab Med 142:1202\u20131215","journal-title":"Arch Pathol Lab Med"},{"key":"937_CR39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/gcc.22878","volume":"59","author":"N Wyvekens","year":"2020","unstructured":"Wyvekens\u00a0N, Valtcheva\u00a0N, Mischo\u00a0A et\u00a0al (2020) Novel morphological and genetic features of fumarate hydratase deficient renal cell carcinoma in HLRCC syndrome patients with a\u00a0tailored therapeutic approach. Genes Chromosom Cancer 59:611\u2013619","journal-title":"Genes Chromosom Cancer"},{"key":"937_CR40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euf.2019.11.013","volume":"7","author":"RG Dinatale","year":"2019","unstructured":"Dinatale RG, Gorelick AN, Makarov V et al (2019) Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging entity with variable clinical course. Eur Urol Focus 7:381\u2013389","journal-title":"Eur Urol Focus"},{"key":"937_CR41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","volume":"28","author":"AA Hakimi","year":"2015","unstructured":"Hakimi\u00a0AA, Tickoo\u00a0SK, Jacobsen\u00a0A et al (2015) TCEB1-mutated renal cell carcinoma: a\u00a0distinct genomic and morphological subtype. Mod Pathol 28:845\u2013853","journal-title":"Mod Pathol"},{"key":"937_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.11.013","author":"RG Dinatale","year":"2019","unstructured":"Dinatale RG, Gorelick AN, Makarov V et\u00a0al (2019) Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging entity with variable clinical course. Eur Urol Focus https:\/\/doi.org\/10.1016\/j.euf.2019.11.013","journal-title":"Eur Urol Focus"},{"key":"937_CR43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","volume":"28","author":"AA Hakimi","year":"2015","unstructured":"Hakimi\u00a0AA, Tickoo\u00a0SK, Jacobsen\u00a0A et al (2015) TCEB1-mutated renal cell carcinoma: a\u00a0distinct genomic and morphological subtype. Mod Pathol 28:845\u2013853","journal-title":"Mod Pathol"},{"key":"937_CR44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/PAS.0000000000001422","volume":"44","author":"RB Shah","year":"2020","unstructured":"Shah\u00a0RB, Stohr\u00a0BA, Tu\u00a0ZJ et\u00a0al (2020) \u201cRenal cell carcinoma with leiomyomatous stroma\u201d harbor somatic mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): clinicopathologic and molecular characterization of 18 sporadic tumors supports a\u00a0distinct entity. Am J Surg Pathol 44:571\u2013581","journal-title":"Am J Surg Pathol"},{"key":"937_CR45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/PAS.0b013e31818fbdff","volume":"33","author":"P Argani","year":"2009","unstructured":"Argani\u00a0P, Aulmann\u00a0S, Karanjawala\u00a0Z et\u00a0al (2009) Melanotic Xp11 translocation renal cancers: a\u00a0distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol 33:609\u2013619","journal-title":"Am J Surg Pathol"},{"key":"937_CR46","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.2005.04.4693","volume":"24","author":"P Argani","year":"2006","unstructured":"Argani\u00a0P, La\u00e9\u00a0M, Ballard\u00a0ET et\u00a0al (2006) Translocation carcinomas of the kidney after chemotherapy in childhood. J\u00a0Clin Oncol 24:1529\u20131534","journal-title":"J Clin Oncol"},{"key":"937_CR47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00292-016-0151-2","volume":"37","author":"E Bruder","year":"2016","unstructured":"Bruder\u00a0E, Moch\u00a0H (2016) Das Translokationskarzinom. Pathologe 37:159\u2013165","journal-title":"Pathologe"},{"key":"937_CR48","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00428-019-02526-8","volume":"474","author":"N Wyvekens","year":"2019","unstructured":"Wyvekens\u00a0N, Rechsteiner\u00a0M, Fritz\u00a0C et al (2019) Histological and molecular characterization of TFEB-rearranged renal cell carcinomas. Virchows Arch 474:625\u2013631","journal-title":"Virchows Arch"},{"key":"937_CR49","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/modpathol.2010.213","volume":"24","author":"LV Debelenko","year":"2011","unstructured":"Debelenko\u00a0LV, Raimondi\u00a0SC, Daw\u00a0N et al (2011) Renal cell carcinoma with novel VCL\u2013ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 24:430\u2013442","journal-title":"Mod Pathol"},{"key":"937_CR50","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","volume":"33","author":"N Kuroda","year":"2020","unstructured":"Kuroda\u00a0N, Trpkov\u00a0K, Gao\u00a0Y et al (2020) ALK rearranged renal cell carcinoma (ALK-RCC): a\u00a0multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217. Mod Pathol 33:2564\u20132579","journal-title":"Mod Pathol"},{"key":"937_CR51","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000179","volume":"38","author":"NE Smith","year":"2014","unstructured":"Smith\u00a0NE, Deyrup\u00a0AT, Mari\u00f1o-Enriquez\u00a0A et al (2014) VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Am J Surg Pathol 38:858\u2013863","journal-title":"Am J Surg Pathol"},{"key":"937_CR52","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/modpathol.2012.107","volume":"25","author":"WR Sukov","year":"2012","unstructured":"Sukov\u00a0WR, Hodge\u00a0JC, Lohse\u00a0CM et\u00a0al (2012) ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a\u00a0large series of consecutively treated patients. Mod Pathol 25:1516\u20131525","journal-title":"Mod Pathol"},{"key":"937_CR53","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","volume":"38","author":"J Guo","year":"2014","unstructured":"Guo\u00a0J, Tretiakova\u00a0MS, Troxell\u00a0ML et\u00a0al (2014) Tuberous sclerosis\u2013associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol 38:1457\u20131467","journal-title":"Am J Surg Pathol"},{"key":"937_CR54","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","volume":"44","author":"M Tjota","year":"2020","unstructured":"Tjota\u00a0M, Chen\u00a0H, Parilla\u00a0M et\u00a0al (2020) Eosinophilic renal cell tumors with a\u00a0TSC and MTOR gene mutations are morphologically and Immunohistochemically heterogenous: clinicopathologic and molecular study. Am J Surg Pathol 44:943\u2013954","journal-title":"Am J Surg Pathol"},{"key":"937_CR55","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","volume":"41","author":"K Trpkov","year":"2017","unstructured":"Trpkov\u00a0K, Abou-Ouf\u00a0H, Hes\u00a0O et al (2017) Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a\u00a0distinct entity. Am J Surg Pathol 41:1299\u20131308","journal-title":"Am J Surg Pathol"},{"key":"937_CR56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","volume":"40","author":"K Trpkov","year":"2016","unstructured":"Trpkov\u00a0K, Hes\u00a0O, Bonert\u00a0M et\u00a0al (2016) Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women. Am J Surg Pathol 40:60\u201371","journal-title":"Am J Surg Pathol"},{"key":"937_CR57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/his.13183","volume":"71","author":"SC Smith","year":"2017","unstructured":"Smith\u00a0SC, Sirohi\u00a0D, Ohe\u00a0C et al (2017) A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma. Histopathology 71:42\u201352","journal-title":"Histopathology"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-021-00937-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-021-00937-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-021-00937-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T10:07:45Z","timestamp":1619690865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-021-00937-6"}},"subtitle":["\u00dcbersicht und neue Entwicklungen"],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["937"],"URL":"https:\/\/doi.org\/10.1007\/s00292-021-00937-6","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"8 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"I.\u00a0Polifka, A.\u00a0Agaimy und A.\u00a0Hartmann geben an, dass kein Interessenkonflikt besteht. H.\u00a0Moch ist \u201eStanding Member\u201c des Editorial Boards der Blue Book-Serie \u201eWHO Classification of Tumours\u201c.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}